Topotecan for the treatment of recurrent and stage IVB cervical cancer (TA183)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 28 October 2009
Guidance on the use of liquid-based cytology for cervical screening (TA69)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 22 October 2003
Tisotumab vedotin for treating recurrent or metastatic cervical cancer after systemic therapy [ID3753]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Pembrolizumab with chemotherapy for treating recurrent, persistent or metastatic cervical cancer [ID3798]Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC